Skip to main content
. 2020 Sep 19;26:e924587-1–e924587-11. doi: 10.12659/MSM.924587

Figure 2.

Figure 2

(A–F) represents the proteoglycans and prostacyclin in the control and experimental group of rats. The details of the assay were given in the methodology section. Statistical significance shown as * P<0.05, ** P<0.01, compared to sham-controls, # P<0.05, IDD+apigenin-treated compared to IDD-induced rats.